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Aivar Päären1*, Hannes Bohman1, Anne-Liis von Knorring1, Lars von Knorring2, Gunilla Olsson1 and Ulf Jonsson1,2Abstract
Background: We investigated whether adolescents with hypomania spectrum episodes have an excess risk of
mental and physical morbidity in adulthood, as compared with adolescents exclusively reporting major depressive
disorder (MDD) and controls without a history of adolescent mood disorders.
Methods: A community sample of adolescents (N = 2 300) in the town of Uppsala, Sweden, was screened for
depressive symptoms. Both participants with positive screening and matched controls (in total 631) were
diagnostically interviewed. Ninety participants reported hypomania spectrum episodes (40 full-syndromal, 18 with
brief episode, and 32 subsyndromal), while another 197 fulfilled the criteria for MDD without a history of a
hypomania spectrum episode. A follow up after 15 years included a blinded diagnostic interview, a self-assessment
of personality disorders, and national register data on prescription drugs and health services use. The participation
rate at the follow-up interview was 71% (64/90) for the hypomania spectrum group, and 65.9% (130/197) for the
MDD group. Multiple imputation was used to handle missing data.
Results: The outcomes of the hypomania spectrum group and the MDD group were similar regarding subsequent
non-mood Axis I disorders in adulthood (present in 53 vs. 57%). A personality disorder was reported by 29% of the
hypomania spectrum group and by 20% of the MDD group, but a statistically significant difference was reached
only for obsessive-compulsive personality disorder (24 vs. 14%). In both groups, the risk of Axis I disorders and
personality disorders in adulthood correlated with continuation of mood disorder. Prescription drugs and health
service use in adulthood was similar in the two groups. Compared with adolescents without mood disorders, both
groups had a higher subsequent risk of psychiatric morbidity, used more mental health care, and received more
psychotropic drugs.
Conclusions: Although adolescents with hypomania spectrum episodes and adolescents with MDD do not differ
substantially in health outcomes, both groups are at increased risk for subsequent mental health problems. Thus, it
is important to identify and treat children and adolescents with mood disorders, and carefully follow the continuing
course.
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Owing to the severity of bipolar disorder [1], there is
great interest in child and adolescent symptoms of hypo-
mania and whether these symptoms will subsequently
develop into bipolar disorder. Long-term follow-up stud-
ies have shown different results, depending on the sam-
ple and methodology. On the one hand, several clinical
samples suggest a continuity of the disorder from child-
hood and adolescence to early adulthood [2-7]. The con-
tinuing course in clinical samples might to some extent
be explained by the severity of the disorder and high
rates of family history of bipolar disorder in this group.
On the other hand, community samples do not sug-
gest a clear continuity. In a 15-year follow-up of the US
Oregon study of high school students aged 14–18 years,
only 3.4% of those with subsyndromal hypomania symp-
toms developed bipolar disorder [8]. An earlier follow-
up of the US Oregon study reported that 9 out of the 17
(53%) youths with syndromal bipolar disorder (4 bipolar
I, 11 bipolar II, and 2 cyclothymic) failed to recover or
had at least one recurrence by the age of 24 years [9]. A
prospective longitudinal community sample in Munich
[10], of adolescents and young adults aged 14–24 years,
found that 7.2% of the participants with subthreshold bi-
polar disorder at baseline converted to bipolar disorder
during a 10 years follow-up, compared to 1.7% with pure
MDD. Additionally, in a recent 15-year follow up of a
Swedish community sample of adolescents with mood
disorders, we found that only 6 out of 64 participants
(9%) with hypomania spectrum episodes in adolescence
reported either a manic or hypomanic episode in adult-
hood [11]. Thus, the results suggest that hypomania
spectrum episodes in adolescence do not necessarily lead
to bipolar disorder. In addition, several longitudinal
studies of high-risk offspring with a family history of bi-
polar disorder indicate a relatively small increased risk
of developing bipolar disorders in adulthood [12-16].
However, there might be concerns that hypomanic
symptoms in adolescence indicate excess risk of other
health conditions. Many epidemiological studies show
that comorbidity is common in children and adolescents
with syndromal and subsyndromal bipolar disorder
[3,17-19]. Child and adolescent bipolar disorder is
highly comorbid with attention-deficit/hyperactivity dis-
order (ADHD), anxiety disorders, obsessive-compulsive
disorder (OCD), conduct disorder (CD), post-traumatic
stress disorder (PTSD) and substance abuse [20-26].
Also high-risk offspring studies have reported elevated
rates of a broad range of psychiatric comorbid disorders,
although the rates of ADHD and CD have been rela-
tively low [12,16,27,28].
In adults with bipolar spectrum disorder, high rates
of comorbidity for anxiety disorders, substance abuse
and personality disorders are reported [29-37]. Recentdata also suggest increased comorbid substance/alcohol
abuse and anxiety in adults with MDD and subsyndromal
hypomanic features, compared to individuals with MDD
without a history of subsyndromal hypomanic features
[10,38].
Further, personality disorders are frequently associated
not only with mood disorders in general but also with
bipolar disorder [32,33,35,36,39]. Personality disorders
are more common in individuals with an early onset of
bipolar disorders than in those with a late onset [39,40].
Some studies suggest that comorbid personality disor-
ders reduce the likelihood of recovery from early-onset
forms of mood disorders [37,41]. Also, ADHD and eat-
ing disorders are common comorbid disorders in adults
with bipolar disorder [31,42], although ADHD seems to
be more prevalent in children and adolescents than in
adults [20,21,31,43].
Thus, there are reasons to think that the broader
spectrum of hypomania in adolescence might be a
marker for various kinds of non-mood morbidity. In the
present study we investigated the broader health out-
comes of adolescents with hypomania spectrum symp-
toms. In addition to measures of psychiatric non-mood
morbidity, register data on health care utilization were
used as proxy measures of disease and related health
problems. To test the specificity of adolescent hypo-
mania spectrum, we compared this disorder with ado-
lescent MDD without a history of hypomania spectrum
episodes. Four main research questions were addressed:
1. Do individuals with a history of hypomania
spectrum episodes in adolescence have an excess
risk of non-mood Axis I disorders or personality
disorders as adults, compared with adolescents
with MDD without a history of hypomania spectrum
episodes and with controls without a history of
adolescent mood disorders?
2. Is the pattern of overlap between anxiety disorders,
substance abuse and personality disorders in adults
with a history of hypomania spectrum episodes in
adolescence similar to or different from that of
individuals with a history of MDD in adolescence
and that of controls without mood disorders in
adolescence?
3. Is the risk of adult non-mood Axis I disorders and
personality disorders in individuals with hypomania
spectrum episodes or MDD in adolescence related
to the continuity of the mood disorders?
4. Do individuals with hypomania spectrum episodes in
adolescence utilize more health services and
prescription drugs as adults than adolescents with
MDD without a history of hypomania spectrum
episodes and controls without mood disorders in
adolescence?
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Study design and participants
The present study is based on a community study car-
ried out during 1991–93 in the Swedish university town
of Uppsala (pop. approximately 180 000). All first year
students in upper secondary school (16–17 years of age),
and school dropouts of the same age, were invited to a
screening for depression [44]. Out of a total of 2 465 ado-
lescents in the age group, 2 300 (93%) participated in the
screening. Both adolescents with positive screening and
controls (in total 631) were diagnostically interviewed.
In total, 409 (64.6%) of the original participants took
part in a follow-up interview after 15 years [45]. Out of
the 222 participants who did not take part, 22 (3.5%)
had not given their consent to the follow-up study, 39
(6.2%) had emigrated or lived abroad at the time of the
follow-up, 3 (0.5%) were not alive, 42 (6.7%) could not
be reached, and 116 (18.5%) either refused or could not
find the time. The age of the participants ranged be-
tween 30 and 33 years (mean = 31.6 years; SD = 0.8) at
the time of the follow-up interview. The procedure is
outlined in Figure 1.
Data collection
The screening in adolescence was performed with two
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Figure 1 Chart illustrating the selection of participants and division in
reports describing this cohort, it should be noted that some subjects previ
classified as having hypomania spectrum.Depression Inventory-Child (BDI-C) [46] and the Centre
for Epidemiological Studies – Depression Scale for
Children (CES-DC) [47]. Students with positive scree-
ning (BDI ≥ 16 or CES-DC ≥ 30 + BDI ≥ 11, or a previous
suicide attempt) were interviewed with the Diagnostic
Interview for Children and Adolescents in the revised
form according to DSM-III-R for adolescents (DICA-R-A)
[48]. For each student with a positive screening, a same
sex classmate with negative screening was interviewed
in the same manner. In total, 631 adolescents were
interviewed and asked for consent to be contacted for a
follow-up study.
Fifteen years later, in 2006–2008, a follow-up diagnos-
tic interview was performed with the Mini International
Neuropsychiatric Interview Plus (MINI Plus) [49]. At the
time of the follow-up interview, the participants also com-
pleted the DSM-IV – ICD-10 Personality Questionnaire
(DIP-Q) [50]. We also asked the participants for informed
consent to link the data from the interviews to data from
the Swedish national registers.
Definition of the groups: Hypomania spectrum, major
depressive disorder, and controls
In this study, hypomania was defined as “elevated mood”
and/or “grandiosity” and 1–3 additional symptoms, or
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this definition was that elevated mood and/or grandios-
ity can be considered as the “cardinal features” of mania
and have been proposed as required symptoms in children
and adolescents with hypomania [51]. Thus, only irritable
mood was not sufficient as the core symptom unless gran-
diosity and/or elevated mood were also present [4,51].
This approach was adopted to avoid overlap with dimen-
sional irritability/aggression, which is present across differ-
ent child and adolescent mental disorders (e.g., ADHD,
CD, ODD, MDD, PTSD, and disruptive mood dysregula-
tion disorder).
Based on the base-line evaluation in adolescence, the
participants were divided into subgroups as follows:
1. Hypomania spectrum was defined as full-syndromal
hypomania (criteria for hypomania were fulfilled for
at least 4 days duration), brief-episode hypomania
(the symptom criteria for hypomania were fulfilled,
but for less than 4 days), or subsyndromal
hypomania (1 or 2 main symptoms and 1–2
additional symptoms, with a total of ≥3 symptoms
fulfilled; the duration was not defined, but was in
most of the cases more than four days).
2. Major Depressive Disorder (MDD) was defined
according to DSM-IV criteria.
3. Controls did not fulfill the criteria for MDD or
dysthymia, did not screen positive for depression,
and did not report a hypomania spectrum episode.
The sample included 90 participants with hypomania
spectrum (40 full-syndromal, 18 with brief episode, and
32 subsyndromal), 197 participants with MDD and 229
controls. One adolescent fulfilled the criteria for a manic
episode, and was excluded from the analyses.
Participants meeting the criteria for hypomania spectrum
both among those with positive and negative screening
were categorized as having hypomania spectrum.
Participants with dysthymia or positive screening for
depression, but who did not fill the criteria for hypomania
spectrum or MDD, were defined as having subthreshold
depression and were excluded from the present study
(Figure 1). It should be noted that in a previous study of
this population, subjects with mania/hypomania were ex-
cluded [45]. Therefore, the size of the groups in this study
and the previous one are not identical.
Baseline evaluation
Adolescent mood disorders and other mental disorders
were assessed with the DICA-R-A. Previous childhood
anxiety disorders, ADHD, ODD, and hypomania were also
retrospectively assessed with the DICA-R-A. Additional in-
formation on depressive symptoms was available from the
BDI-C and CES-DC scores. Among those with hypomaniaspectrum who had screened positively for depression, 53
met the criteria for a lifetime major depression and 9 had
subthreshold depression/dysthymia. Among those with
hypomania spectrum who had screened negatively for
depression, 15 had a lifetime major depression, 1 had sub-
threshold depression, and 12 had no depression. To ascer-
tain that the symptoms were not better explained by
ADHD, we assessed that the 12 participants in the hypo-
mania group without depression did not meet the criteria
for ADHD. The interviews were performed as soon as pos-
sible after the screening: 37% within one month, 20% dur-
ing the second, 14% during the third, 13% during the
fourth, 13% during the fifth and sixth months, and 3%
later. More than half of the interviews were performed by
the same psychiatrist and the remaining by two psychiatry
nurses, two psychologists and one student. They were all
individually trained by the psychiatrist. In 27 of the inter-
views, another psychiatrist conducted simultaneous scoring
with the interviewer. There were no differences in diagnos-
tic results and only small discrepancies in details. Details
about the baseline evaluation have been published previ-
ously [44,52].
The proportion of females was 70% in the hypomania
spectrum group, compared with 85% in the MDD group
and 79% of the controls. The hypomania group and the
MDD group differed significantly in this respect (p < 0.05).
The DICA-R-A also included questions about psycho-
social stressors in adolescence. There were no significant
differences between the hypomania spectrum group and
the MDD group regarding economical hardships within
the family (8.9 vs. 15.3%), parental unemployment (13.3
vs. 15.2%), and parental divorce (33.3 vs. 31.5%).
The adolescents with mood disorders reported a high
comorbidity with axis I disorders: 78% of those with
hypomania spectrum episodes reported at least one co-
morbid diagnosis in adolescence or childhood, compared
with 80% of those with MDD and 25% of the controls
(Table 1). The adolescents with hypomania spectrum dis-
order had a significantly higher prevalence of psychotic
symptoms (p < 0.05) than the adolescents with MDD, and
there was a non-significant trend suggesting that conduct
disorder was also more common in the hypomania
spectrum group (p = 0.069). For all the other non-mood
disorders, the prevalence was similar in the two groups.
Within the hypomania spectrum group, comorbidity
did not differ much between males and females, with the
exception that boys had a higher prevalence of ADHD
(26 vs. 10%; χ2 = 4.1; p < 0.05).
Follow-up evaluation
At age 30–33 years, the participants were diagnostically
interviewed with the MINI Plus. Some non-mood disor-
ders were assessed from age 19 years to follow up (panic
disorder and agoraphobia, alcohol abuse or dependence,
Table 1 Mental comorbidity in adolescents with hypomania spectrum episodes or major depressive disorder (MDD)
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Separation anxiety disorder 20 (50) 32 (36) 77 (39) 26 (11) 0.88 (052–1.48) 4.49 (2.46-8.18)***
Avoidant disorder 7 (18) 14 (16) 23 (12) 4 (2) 1.42 (0.69-2.95) 10.10 (3.21-31.74)***
Overanxious disorder 16 (40) 27 (30) 74 (38) 10 (4) 0.71 (0.41-1.22) 9.42 (4.31-20.58)***
Panic disorder 5 (13) 12 (13) 26 (13) 2 (1) 1.09 (0.52-2.30) 19.96 (4.33-91.94)***
OCD 18 (45) 26 (29) 47 (24) 10 (4) 1.30 (073–2.29) 9.23 (4.20-20.28)***
PTSD 2 (5) 3 (3) 11 (6) 1 (0) 0.57 (0.15-2.11) 7.96 (0.81-78.26)
Psychotic symptoms 4 (10) 9 (10) 6 (3) - 3.67 (1.25-10.82)* - 1
Anorexia nervosa - - 10 (5) 1 (0) - 1 - 1
Bulimia nervosa - 1 (1) 3 (2) - 0.88 (0.09-8.64) - 1
ADHD 8 (20) 13 (14) 20 (10) 2 (1) 1.24 (0.57-2.70) 17.70 (3.87-80.85)***
CD 12 (30) 29 (32) 39 (20) 10 (4) 1.71 (0.96-3.05) 10.24 (4.72-22.23)***
ODD 4 (10) 8 (9) 20 (10) 2 (1) 0.91 (0.38-2.18) 11.55 (2.39-55.85)**
Drug/sniffing/alcohol abuse 5 (13) 12 (13) 16 (8) 2 (1) 1.56 (0.69-3.52) 18.17 (3.96-83.42)***
Any comorbidity 34 (85) 70 (78) 157 (80) 58 (25) 0.89 (0.48-1.65) 10.56 (5.88-18.97)***
* <0.05; ** <0.01; *** < 0.001.
aFull-syndromal hypomania is included in all hypomania spectrum, but is also presented separately for transparency.
bAll p-values adjusted for sex in a logistic regression model.
1Adjustment for sex was not possible owing to missing symptoms in comparison group.
MDD: Major Depression; OCD: Obsessive-compulsive disorder; PTSD: Posttraumatic stress disorder; ADHD: Attention-deficit/hyperactivity disorder; CD: Conduct
disorder; ODD: Oppositional defiant disorder; OR: Odds ratio; CI: Confidence interval.
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tus at follow-up was assessed for the other non-mood
disorders.
Five interviewers trained in clinical psychology or psych-
iatry conducted the follow-up interviews. They were
blinded to which subgroup the participants belonged. To
enhance inter-rater reliability, one interview for each inter-
viewer was video-recorded and rated by the other inter-
viewers. These recordings yielded an overall (for all the
included diagnoses in MINI) free-marginal kappa value of
0.93. To further increase reliability, and to ensure the
clinical validity of the diagnoses, uncertainties were regu-
larly discussed with senior psychiatrists during sessions of
group supervision.
Attrition to follow-up
The participant rate at follow-up for the total hypomania
spectrum group was 71% (64/90): 67.5% (27/40) for full-
syndromal hypomania, 66.7% (12/18) for brief-episode
hypomania and 78.1% (25/32) for subsyndromal hypo-
mania. Participation rate was 65.9% (130/197) for the
MDD group, and 64.6% (148/229) for the control group.
The participation rate did not differ significantly between
the groups. To assess dissimilarities between those who
were lost to follow-up and those who participated in eachgroup, these two groups were compared regarding child
and adolescent mental disorders and sex. The groups were
similar, with the exception that OCD was significantly
more common among those who did not participate in
the follow-up (46 vs. 22 %; χ2 = 5.31; p = 0.021) (Additional
file 1: Table S1).
The Swedish national registers
The National Board of Health and Welfare keeps the of-
ficial registers concerning health and sickness in Sweden.
The Patient Register contains psychiatric in-patient care
on a national level since 1973, all in-patient care since
1987, and outpatient care (primary care excluded) since
2001. The purpose of this register is to follow the develop-
ment of health in the population, to obtain information
on health care use, to improve the abilities of prevention
and treatment of disease and to contribute to the progress
of health care.
The Prescribed Drug Register contains information on
all dispensed prescribed drugs to the entire Swedish popu-
lation from 1999 and onwards. The personal identity
number has been available since July 2005. The quality is
regarded as very good, and only 0.3% of the records lack
information on the personal identity number. All drugs
are classified according to the Anatomical Therapeutic
Päären et al. BMC Psychiatry 2014, 14:9 Page 6 of 15
http://www.biomedcentral.com/1471-244X/14/9Chemical (ATC) classification system. Measurement units
of use are prescriptions, Defined Daily Doses (DDDs) and
expenditures. Updates are carried out monthly.
After informed consent, we obtained data on registered
inpatient care (including delivery) during the years 1992
through 2009 and outpatient care during the years 2001
through 2009 with the diagnoses according to the Inter-
national Classification of Diseases, 10th edition (ICD-10).
The diagnoses were grouped according to the chapters in
ICD-10, except for Chapter V, mental and behavioral
disorders, where each block was grouped and analyzed
separately.
Following the same procedure, data on prescription
drugs during the years 2005 through 2009 were obtained
and categorized according to the ATC. The drugs were
grouped according to the ATC main groups, with the
exception of the nervous system (N01-N07) in which
each pharmacological/therapeutic subgroup was grouped
and analyzed separately.
Data was obtained for 64.4% (58/90) of the hypomania
spectrum group, 64.5% (127/197) of the MDD group,
and 64.2% (147/229) of the controls.Statistical analyses
The baseline characteristics and outcomes in the three
groups (hypomania spectrum, MDD and controls) were
compared by univariate logistic regression analyses. As
the hypomania spectrum group had a significantly higher
proportion of males than the MDD group at baseline, all
analyses were also done with logistic regression adjusted
for sex. Only the adjusted odds ratios (ORs) with 95% con-
fidence intervals (CIs) are presented.
Owing to skew distributions, differences between means
were tested with of the Mann Whitney U test. The sub-
groups of hypomania spectrum (full-syndromal, brief epi-
sode, and subsyndromal) were deemed to be too small to
be analyzed separately. However, all background charac-
teristics and outcomes are presented separately for the
participants with full-syndromal hypomania, to increase
transparency.
To address the problem with loss of information and
possible bias because of attrition, a multiple imputation
approach was adopted for the logistic regression analyses.
Missing values on all outcome variables were imputed
with a model consisting of group (hypomania spectrum,
MDD, and controls) and all the variables presented in
Table 1. Following the recommendations of Graham and
colleagues [53], twenty data sets were imputed; the
pooled estimates of these were computed. In addition,
complete-cases analyses of all models were conducted.
P-values of less than 0.05 were reported as signifi-
cant. All statistical analyses were performed with the
SPSS 21.0.Ethics
The study was approved by the local ethical vetting
board of Uppsala University, Sweden.
Results
Non-mood Axis I disorders at follow-up
A non-mood disorder on Axis I was reported at follow-
up by 34 (53%) of the hypomania spectrum group, com-
pared with 74 (57%) of the MDD group, and 41 (28%) of
the controls (Table 2).
The most prevalent disorders were anxiety disorders.
There were no significant differences between the hypo-
mania spectrum group and the MDD group regarding
any of the investigated Axis I disorders in the complete
cases analyses. In the analyses with multiple imputations,
no significant differences were found except for PTSD
and Bulimia nervosa, although the prevalence of these
disorders was low (Table 2).
Personality disorders at follow-up
A personality disorder in adulthood was reported by 18
(29%) of the participants with hypomania spectrum in
adolescence, compared with 26 (20%) of those with ado-
lescent MDD, and 12 (8%) of the controls (Table 3).
A cluster A disorder in adulthood was reported by 13
(21%) of the participants with hypomania spectrum in
adolescence, compared with 16 (12%) of those with ado-
lescent MDD, and 5 (3%) of the controls. A cluster B
disorder in adulthood was reported by 6 (10%) of the
participants with hypomania spectrum in adolescence,
compared with 18 (14%) of those with adolescent MDD,
and 4 (3%) of the controls. A cluster C disorder in adult-
hood was reported by 18 (29%) of the participants with
hypomania spectrum in adolescence, compared with 23
(17%) of those with adolescent MDD, and 12 (8%) of the
controls.
The most prevalent personality disorders in the hypo-
mania spectrum group were obsessive compulsive (24%),
avoidant (18%), and paranoid personality disorder (16%).
There were few cases of borderline (10%), antisocial
(3%), and schizotypal personality disorder (2%). No sig-
nificant differences were found between the hypomania
spectrum group and the MDD group in the complete-
cases analyses. In the analyses with multiple imputation,
no significant differences were observed between the
hypomania spectrum and MDD groups with the exception
of obsessive-compulsive personality disorder which was
significantly more prevalent in the hypomania spectrum
group (Table 3).
Overlap of anxiety disorders, substance abuse and
personality disorders at follow-up
Venn diagrams were used to illustrate how anxiety disor-
ders, substance abuse, and personality disorders overlapped
Table 2 Adult non-mood Axis I disorders in a 15-year follow-up of adolescents with hypomania spectrum disorder or major depressive disorder (MDD) and of
non-mood controls
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GADb 6 (22) 12 (19) 19 (15) 7 (5) 1.51 (0.67-3.39) 5.15 (1.90-13.97)*** 1.36 (0.64-2.90) 5.72 (2.25-14.58)***
Panic disorderc 6 (22) 14 (22) 23 (18) 11 (7) 1.55 (0.72-3.33) 3.82 (1.61-9.08)** 1.77 (0.87-3.57) 5.01 (2.22-11.29)***
Social anxietyc 5 (19) 11 (17) 27 (21) 10 (7) 0.75 (0.34-1.64) 2.79 (1.11-6.99)* 0.61 (0.29-1.27) 3.36 (1.37-8.27)**
Agoraphobiac 6 (22) 14 (22) 28 (22) 12 (8) 1.14 (0.55-2.39) 3.48 (1.49-8.15)** 1.03 (0.54-1.98) 4.23 (1.94-9.21)***
OCDb - 4 (6) 6 (5) 2 (1) 1.67 (0.45-6.21) 5.62 (0.99-31.81) 1.42 (0.38-5.32) 4.83 (0.87-27.80)
PTSDb - 4 (6) 1 (1) - 8.97 (0.97-83.25) - 1 9.20 (1.06-79.93)* - 1
Somatization disorderb - 1 (2) 3 (2) - 0.59 (0.07-5.47) - 1 0.64 (0.07-5.83) - 1
Dysmorphophobiab 1 (4) 3 (5) 5 (4) 1 (1) 1.48 (0.34-6.46) 8.30 (0.84-81.98) 1.12 (0.26-4.95) 8.66 (0.89-84.49)
Bulimia nervosab 1 (4) 3 (5) 2 (2) - 3.80 (0.61-23.55) - 1 8.66 (1.66-48.09)* - 1
Psychotic symptomsb - - 2 (2) 2 (1) - 1 - 1 - 1 - 1
ADHDb - 2 (3) 1 (1) 1 (1) 3.85 (0.33-44.89) 4.55 (0.40-51.84) 2.93 (0.24-36.02) 4.82 (0.44-52.41)
Alcohol abusec 4 (15) 10 (16) 17 (13) 11 (7) 1.29 (0.55-3.05) 2.19 (0.87-5.49) 1.39 (0.67-2.87) 3.52 (1.53-8.10)**
Drug abusec - 4 (6) 8 (6) 3 (2) 2.00 (0.27-15.00) 5.41 (0.48-61.15) 3.75 (0.72-19.53) 14.79 (1.70-128.94)*
Any non-mood morbidity 15 (56) 34 (53) 74 (57) 41 (28) 0.86 (0.46-1.58) 2.98 (1.62-5.50)*** 0.85 (0.48-1.51) 4.04 (2.29-7.16)***
* <0.05; ** <0.01; *** < 0.001.
aFull-syndromal hypomania in the follow up is included in all hypomania spectrum, but is also presented separately for transparency.
bCurrent at follow-up.
cAny time from age 19 to follow-up.
dAll p-values adjusted for sex in a logistic regression model.
1Missing cases in the comparison group; could therefore not be analyzed.
MINI: MINI International Neuropsychiatric Interview Plus; MDD: Major depressive disorder; GAD: Generalized anxiety disorder; OCD: Obsessive-compulsive disorder; PTSD: Posttraumatic stress disorder; ADHD:

















Table 3 Adult personality disorders in a 15-year follow-up of adolescents with hypomania spectrum disorder or major depressive disorder (MDD) and of
non-mood controls
Personality disorders (DIP-Q) Full-syndromal
hypomaniaa
n = 26 (%)
All hypomania
spectrum
n = 62 (%)
MDD
n = 133 (%)
Control
n = 149 (%)













Cluster A (odd or eccentric)
Any cluster A disorder 7 (27) 13 (21) 16 (12) 5 (3) 1.98 (0.88-4.46) 7.54 (2.55-22.26)*** 1.59 (0.69-3.69) 6.39 (2.10-19.49)**
Paranoid personality 5 (19) 10 (16) 12 (9) 4 (3) 1.96 (0.79-4.86) 6.73 (2.02-22.50)** 1.40 (0.64-3.05) 8.02 (2.39-26.88)***
Schizoid personality - 1 (2) 3 (2) 1 (1) 0.83 (0.08-8.19) 2.64 (0.16-43.18) 0.84 (0.09-8.06) 2.96 (0.18-48.46)
Schizotypal personality 3 (12) 8 (13) 9 (7) 4 (3) 2.07 (0.75-5.73) 5.34 (1.54-18.53)** 2.07 (0.76-5.60) 5.50 (1.59-19.04)**
Cluster B (dramatic, emotional, or erratic)
Any cluster B disorder 2 (8) 6 (10) 18 (14) 4 (3) 0.68 (0.26-1.84) 4.12 (1.11-15.26)* 0.69 (0.25-1.88) 4.03 (1.12-14.48)*
Antisocial personality 1 (4) 2 (3) 2 (2) - 2.09 (0.28-15.64) - 1 1.94 (0.26-14.22) - 1
Borderline personality 2 (8) 6 (10) 14 (11) 4 (3) 0.98 (0.35-2.71) 4.12 (1.11-15.26)* 0.89 (0.36-2.21) 4.98 (1.40-17.68)*
Histrionic personality 1 (4) 3 (5) 3 (2) - 1.97 (0.38-10.36) - 1 1.67 (0.33-8.56) - 1
Narcissistic personality - 2 (3) 5 (4) - 1.07 (0.86-1.34) - 1 0.86 (0.17-4.43) - 1
Cluster C (anxious or fearful)
Any cluster C disorder 9 (35) 18 (29) 23 (17) 12 (8) 1.85 (0.90-3.80) 4.61 (2.06-10.33)*** 1.69 (0.84-3.40) 4.25 (1.90-9.50)***
Avoidant personality 5 (19) 11 (18) 17 (13) 6 (4) 1.43 (0.62-3.30) 5.14 (1.80-14.66)** 1.15 (0.52-2.54) 4.90 (1.69-14.18)**
Dependent personality 2 (8) 2 (3) 6 (5) 1 (1) 0.83 (0.16-4.25) 5.41 (0.48-61.15) 0.48 (0.10-2.24) 5.54 (0.49-62.76)
Obsessive-compulsive personality 7 (27) 15 (24) 19 (14) 11 (7) 1.83 (0.85-3.95) 3.90 (1.67-9.12)** 2.29 (1.13-4.64)* 5.42 (2.44-12.05)***
Any personality disorder 9 (35) 18 (29) 26 (20) 12 (8) 1.61 (0.80-3.26) 4.61 (2.06-10.33)*** 1.74 (0.92-3.31) 6.63 (2.93-15.00)***
* <0.05; ** <0.01; *** < 0.001.
aFull-syndromal hypomania in the follow up is included in all hypomania spectrum, but is also presented separately for transparency.
bAll p-values adjusted for sex in a logistic regression model.
1Missing cases in the comparison group; could therefore not be analyzed.

















Päären et al. BMC Psychiatry 2014, 14:9 Page 9 of 15
http://www.biomedcentral.com/1471-244X/14/9in the three groups at follow up (Figure 2). The pattern of
overlap was similar for the hypomania spectrum group and
the MDD group. In the control group, these disorders were
less common and the overlap of the disorders was less
extensive.
Association between continued mood disorders and adult
non-mood disorders
Continued mood disorder in adulthood (MDD, bipolar
disorder, or dysthymia) was reported by 60.9% of theFigure 2 Venn diagrams illustrating the overlap of adult
anxiety disorders (Anx.), substance use disorders (SUD) or
personality disorder (PD) in former adolescents with
hypomania spectrum or major depressive disorder (MDD) and
in controls. All values shown as %.hypomania spectrum group and by 70.0% of the MDD
group. Within the hypomania spectrum group, an adult
non-mood disorder on Axis I was reported by 74% of
those with continued mood disorder and 24% of those
with no continued mood disorder (OR 9.18; CI 95% 2.86
to 29.46). An adult personality disorder was reported by
42% of those with continued mood disorder, and by 9%
of those without continued mood disorder (OR 7.64; CI
95% 1.56 to 37.33).
Within the MDD group, an adult non-mood disorder
on Axis I was reported by 73% of those with continued
mood disorder and 31% of those with no continued mood
disorder (OR 5.94; CI 95% 2.61 to 13.50). An adult person-
ality disorder was reported by 26% of those with contin-
ued mood disorder, and by 8% of those without continued
mood disorder (OR 4.07; CI 95% 1.14 to 14.49).
Health service use and prescription drugs in adulthood
The mean number of outpatient visits of the hypomania
spectrum group during follow-up did not differ signifi-
cantly from the MDD group (OR 11.7; 95% CI 8.6 to
14.8 vs. OR 12.3; 95% CI 9.7 to 15; n.s.), but was signifi-
cantly higher than in the control group (OR 6.8; 95% CI
5.2 to 8.4; p < 0.01). The mean number of inpatient visits
in adulthood was similar in the hypomania spectrum
group (OR 2.3; 95% CI 1.7 to 3.0), the MDD group (OR
2.8; 95% CI 2.1 to 3.6) and the control group (OR 1.8;
95% CI 1.4 to 2.2). The proportion that had been treated
for a mental disorder did not differ between the hypo-
mania spectrum group and the MDD group (24 vs. 21%;
n.s.), but was lower in the control group (24 vs. 7%; p <
0.001). For the specific blocks within ICD-10 Chapter V,
mental and behavioral disorders, only the hypomania
group differed from the control group concerning the
block of neurotic, stress-related and somatoform disor-
ders (Table 4).
The proportions that had been treated for a somatic dis-
order were 83% in the hypomania spectrum group, 86% in
the MDD group, and 80% in the control group. The hypo-
mania spectrum group did not differ from the MDD and
controls, with two exceptions: Diseases of the digestive
system and injury, poisoning and certain other conse-
quences of external causes (including attempted suicide)
were less common in the control group (Table 4).
In the complete-cases analyses, there were no significant
differences between the hypomania spectrum and MDD
groups regarding the proportions that had received pre-
scription drugs, with the exception that a larger proportion
of the hypomania spectrum group received prescriptions
for antineoplastic and immunomodulating agents. Both
groups were more likely than the controls to be prescribed
antidepressants, anxiolytics, antipsychotics and drugs for
addictive disorders. In the analyses with multiple imput-
ation, similar estimates were obtained, with the exception
Table 4 Adult in- or outpatient care (ICD-10 codes) and prescription drugs (ATC groups) in a 15-year follow-up of adolescents with hypomania spectrum
disorder or major depressive disorder (MDD) and of non-mood controls
Health service use and prescription drugsa Full-syndromal
hypomaniab
n = 25 (%)
All hypo-mania
spectrum
n = 58 (%)
MDD
n = 127 (%)
Controls
n = 147 (%)













In- or outpatient care due to mental disorders
F10-19 Substance related dis. 1 (4) 2 (3) 3 (2) 1 (1) 1.18 (0.18-7.69) 4.35 (0.38-50.31) 1.12 (0.18-6.85) 4.86 (0.43-55.16)
F20-29 Schizophrenia and other psychotic dis. - 1 (2) 1 (1) - 1.64 (0.09-29.21) - 1 1.36 (0.08-22.43) - 1
F30-39 Mood dis. 1 (4) 6 (10) 11 (9) 8 (5) 1.41 (0.49-4.07) 2.31 (0.75-7.11) 1.64 (0.67-4.02) 3.97 (1.42-11.09)**
F40-48 Anxiety and somatoform dis. 1 (4) 9 (16) 14 (11) 5 (3) 1.89 (0.75-4.77) 6.22 (1.95-19.83)** 2.10 (0.91-4.84) 8.20 (2.82-23.87)***
F50-59 Eating dis., sleep dis., sexual dysfunct. - 2 (3) 3 (2) 2 (1) 1.45 (0.23-9.27) 2.93 (0.40-21.45) 2.70 (0.58-12.67) 6.24 (1.02-38.02)*
F60-69 Personality dis. - - 4 (3) 2 (1) - 1 - 1 - 1 - 1
In- or outpatient care due to physical diseases
K00-K93 Diseases of the digestive system 7 (28) 15 (26) 23 (18) 18 (12) 1.64 (0.77-3.48) 2.44 (1.13-5.28)* 1.75 (0.87-3.52) 3.38 (1.69-6.79)***
S00-S98 Injury, poisoning and certain other
consequences of external causes
6 (24) 22 (38) 41 (32) 31 (21) 1.17 (0.60-2.27) 2.14 (1.08-4.26)* 1.65 (0.93-2.90) 3.78 (2.09-6.86)***
Prescription drugs
L. Antineoplastic and immunomodulating agents 1 (4) 4 (7) 1 (1) 1 (1) 9.72 (1.04-90.78)* 10.17 (1.10-93.78)* 9.25 (0.98-87.32) 11.17 (1.13-110.00)*
N. Nervous system 9 (36) 29 (50) 74 (58) 59 (40) 1.01 (0.79-1.30) 1.59 (1.19-2.13)** 1.11 (0.62-1.97) 3.23 (1.87-5.57)***
N03 Anticonvulsants - - 6 (5) 1 (1) - 1 - 1 - 1 - 1
N05a Antipsychotics 1 (4) 4 (7) 2 (2) - 4.90 (0.85-28.14) - 1 7.82 (1.53-39.92)* - 1
N05b Anxiolytics 4 (16) 11 (19) 15 (12) 6 (4) 2.02 (0.85-4.82) 5.74 (2.00-16.50)*** 1.80 (0.83-3.87) 7.14 (2.88-17.73)***
N05c Hypnotics and sedatives - 9 (16) 21 (17) 13 (9) 0.82 (0.34-1.96) 1.89 (0.76-4.72) 0.91 (0.42-1.94) 2.57 (1.11-5.93)*
N06a Antidepressants 6 (24) 18 (31) 35 (28) 19 (13) 1.31 (0.65-2.62) 3.06 (1.46-6.42)** 1.33 (0.72-2.46) 4.74 (2.43-9.22)***
N06b Psychostimulants - - 3 (2) - - 1 - 1 - 1 - 1
N07 Drugs for addictive disorders - 2 (3) 6 (5) - 0.88 (0.17-4.52) - 1 0.70 (0.14-3.35) - 1
* <0.05; ** <0.01; *** < 0.001.
aOnly diagnostic groups with significant group differences or of specific interest are shown.
bFull-syndromal hypomania in the follow up is included in all hypomania spectrum, but is also presented separately for transparency.
cAll p-values adjusted for sex in a logistic regression model.
1Missing cases in the comparison group; could therefore not be analyzed.


















Päären et al. BMC Psychiatry 2014, 14:9 Page 11 of 15
http://www.biomedcentral.com/1471-244X/14/9that antipsychotics were prescribed to a significantly larger
proportion of the hypomania spectrum group compared
with the MDD group (Table 4).
Discussion
This 15 year follow-up of a community sample presents
unique results of longitudinal health outcomes of adoles-
cents with hypomania spectrum episodes. In a recent
publication, we reported that adolescents with hypo-
mania spectrum disorders and adolescents with MDD
had a similar risk of continued mood disorders as adults
[11]. The present study uses the same community sam-
ple to investigate if hypomania spectrum in adolescence
is a marker of future excess risk for other mental disor-
ders, high consumption of prescription drugs, and high
health care use. The general pattern of anxiety disorders,
personality disorders, and substance use disorders in
adulthood was similar in the two groups, but clearly dif-
fered from that of the control group. Thus, the results
suggest that adolescent hypomania spectrum and MDD
do not appear to constitute two distinct subgroups in
this respect. Rather, they seem to overlap on an affective
spectrum scale.
Our results might be surprising given previous research
on the extensive comorbidity with bipolar disorder in both
adolescents and adults. Mental disorders such as anxiety
disorders, ADHD, and CD might either precede or coexist
with bipolar disorder [2,3,54-57]. In addition, bipolar
spectrum disorders might also be difficult to differentiate
from ADHD in children and adolescents.
Despite the fact that both the hypomania spectrum and
MDD groups had high prevalences of adolescent external-
izing disorders (CD/ODD/ADHD), few participants met
the criteria for ADHD as adults. This seems to be in line
with previous follow-up studies of hyperactive children
with bipolar disorder, which have not documented a sig-
nificant increased risk of comorbid diagnoses of ADHD in
adults [57-59]. Instead, externalizing disorders with hypo-
mania spectrum might predict subsequent cluster B per-
sonality disorders and other affective disorders, but not
necessarily bipolar disorders [32,37,60,61]. Although hypo-
mania spectrum and externalizing disorders coexist in
adults [31,43,59,62], this seems to be considerably less
common than in children and adolescents [20,21].
Alcohol and substance related problems in the hypo-
mania spectrum and MDD groups were low both in
adolescence and adulthood, despite the co-occurrence of
mood and substance use disorders in previous community
samples [63-65]. The surprisingly low rate of substance
use disorders could be the result of a low response-rate
among individuals with these disorders or of low rates of
substance use in Sweden in general [66].
The hypomania spectrum group and the MDD group
had a similarly high rate of anxiety disorders, both inadolescence and in adulthood. It has been reported that
MDD is comorbid with anxiety disorders in general
[67,68], while comorbid panic disorder and PTSD is espe-
cially prevalent with bipolar II disorder [36,69-72]. How-
ever, neither in adolescence nor adulthood did we find a
higher prevalence of panic disorder in the hypomania
spectrum group. PTSD was only reported by a small pro-
portion in both adolescence and adulthood, precluding
any conclusions about differences between the groups.
Similarly, the prevalence of bulimia nervosa was low con-
sidering the higher rates of comorbidity with bipolar II
and eating disorders in some previous studies [42,71-73].
Both the hypomania spectrum group and the MDD
group also had a high risk of personality disorders as
adults. Previous research has reported overlap between
bipolar spectrum and cluster A and B disorders such as
borderline, antisocial and schizotypal [32,33,39]. Cluster C
disorders have been reported to be more typical of MDD
[74]. In our sample, personality disorders within cluster C
(obsessive-compulsive and avoidant) were the most preva-
lent in both the hypomania spectrum group and MDD
group, while only a few cases with borderline, antisocial
and schizotypal personality disorders were found. The
hypomania spectrum group, and in particular the group
with full-syndromal hypomania in adolescence, seemed to
have a somewhat higher rate of paranoid and obsessive-
compulsive personality disorder than the MDD group.
However, only for obsessive-compulsive personality dis-
order was a statistically significant difference observed.
Finally, health service use and prescription drugs in
adults were similar in the hypomania spectrum and MDD
groups, which further emphasizes that the severity of the
conditions in these groups are similar. However, the in-
creased use of mental health services and psychotropic
drugs in both groups underscores the continuity of mental
and behavioral disorders in adolescents with mood disor-
ders. This confirms the results from other prospective
studies showing that child and adolescent onset mood dis-
orders are associated with higher rates of treatment seek-
ing and use of psychotropic drugs [75,76].
Our results show that the continued course of adoles-
cent mood disorders is strongly associated with non-mood
morbidity in adulthood. From the clinical perspective, it is
therefore important to identify and treat children and
adolescents with mood disorders and to monitor their
continuing course. About two-thirds of adults with mood
disorders report an onset during childhood and adoles-
cence [54,77], and children and adolescents are often
diagnosed many years after the onset of the illness. This
might lead to a longer duration of untreated illness, in-
creased risks of chronicity and social impairment, and
higher health care costs.
In summary, less severe symptoms of hypomania in
adolescence do not seem to constitute a specific marker
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http://www.biomedcentral.com/1471-244X/14/9of continued health problems. These results, in combin-
ation with our previous report on the continuity of
mood disorders in this group, cast doubt on the diagnos-
tic usefulness of a broader spectrum of hypomania in
adolescence. In contrast, short-duration hypomania and
subsyndromal bipolar disorder in adults seems to be as-
sociated with greater comorbidity than MDD [38,78]. It
would be of great interest to further investigate this po-
tential distinction between adolescents and adults. For
instance, developmental aspects might be important to
consider with respect to the potential diagnosis of De-
pressive Episode with Short-Duration Hypomania that
recently was included in the section for conditions for
further study in DSM-V [78].
It is possible that other clinical characteristics are better
predictors of the continued course of psychopathology in
adolescents with mood disorders. We have previously re-
ported that long duration of depression [45] and somatic
symptoms [79] in adolescence predict continued mood
disorder and other forms of psychopathology in adult-
hood, suggesting that such factors might be more import-
ant than hypomanic symptoms per se in this age group.
Much has been published on this topic in the past few
years [12,13,27,28], although specific predictors have been
difficult to find. Therefore, more longitudinal studies are
needed to further explore predictors of poor outcome of
adolescent mood disorders.
Some limitations should be considered. Of the source
population of 2465 adolescents, 93.3% participated in the
original screening [44]. However, out of the 183 high-
school dropouts who were invited, only 86 (53%) partici-
pated in the screening.
A total of 29% of the subjects in the hypomania
spectrum group were lost to follow-up. Although the par-
ticipation rate at follow-up did not differ between the
groups, the subjects lost to follow-up could for instance
represent a group with more severe disorders. However,
analyses of adolescent characteristics suggest that those
lost to follow-up and those who participated had similar
psychopathology in adolescence [11]. We also had access
to register data on inpatient and outpatient care and pre-
scription drugs use for 97% of the original participants
[80,81]. These data were not available separately for the
hypomania spectrum group, but showed that only a few
received inpatient or outpatient care for mental disorders.
Thus, it is unlikely that we have missed a large number of
individuals with severe conditions.
Except for inpatient care, the register data on special-
ized outpatient care and the register data on prescription
drugs do not cover the whole follow-up period. Further-
more, data from primary care were not available. But,
although the data concerning health care use and pre-
scription drug use is an underestimation of the true use
of health care and prescription drugs, there is no reasonto believe that the lack of data affected any of the groups
in particular. Thus, the comparison between the groups
should be valid.
Another possible limitation is that the original com-
munity study was designed to screen for depression and
not for hypomania. However, 317 controls with negative
screening were also diagnostically interviewed. In addition,
numerous studies [27,57,82-87] have demonstrated that
early onset of depressive disorders in children or adoles-
cents usually precedes bipolar disorder. Still, there are a
few studies [6,21] that have reported atypical mania-like
symptoms in young children, mainly comorbid with
ADHD. A fully representative sample of adolescents with
hypomania spectrum episodes might show a slightly differ-
ent comorbidity pattern in adulthood.
Further, there is a risk that we failed to identify im-
portant confounders. We adjusted the analyses for sex,
and the information we had on socio-economic status
and social stressors indicated that there were no signifi-
cant differences between the hypomania spectrum group
and the MDD group. However, residual confounding is
possible.
A further limitation is the general risk of type II errors
because of the relatively small number of participants.
Thus, it is not possible to conclude that the outcome of
adolescents with hypomania spectrum and MDD is
equivalent. However, the data suggest that there are no
fundamental differences between the groups.
Conclusions
We conclude that the adult health outcomes do not dif-
fer fundamentally between adolescents with hypomania
spectrum episodes and adolescents with MDD. Thus,
adolescent hypomania spectrum episodes might not be a
marker for worse health outcomes among adolescents
with mood disorders. However, adolescents with mood
disorders in general are at increased risk of subsequent
health problems and could benefit from better treatment
and follow-up. Clinicians should use a developmentally
sensitive approach to early detection, prevention and treat-
ment of mood disorders in children, adolescents, and
young adults.
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